SCHEMBL8287196

SCHEMBL8287196

O=Cc1cc2c(cn1)c(=O)cc(Nc1ccccc1)n2-c1ccccc1

nearest known ligand 0.37

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
GSK3B P49841 3/20 0.37
CDK4 P11802 2/20 0.37
CCND1 P24385 1/20 0.37
CCND2 P30279 1/20 0.37
CCND3 P30281 1/20 0.37
PDE11A Q9HCR9 1/20 0.36
GAA P10253 2/20 0.34
HPGD P15428 2/20 0.34
MAPK1 P28482 2/20 0.34
EGFR P00533 2/20 0.32
BTK Q06187 1/20 0.32
MAT2A P31153 3/20 0.32
ALDH1A1 P00352 1/20 0.32
LMNA P02545 1/20 0.32
HTT P42858 1/20 0.32
SMN1; SMN2 Q16637 1/20 0.32
MEN1 O00255 1/20 0.32
KMT2A Q03164 1/20 0.32
P2RX7 Q99572 1/20 0.31
CDK6 Q00534 1/20 0.31

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL8287440 0.85 GSK3B (0.36) GSK3BCDK4CCND1CCND2CCND3
SCHEMBL8362929 0.84 PIK3CA (0.44) GSK3BCDK4CCND1CCND2CCND3
SCHEMBL5871843 0.83 MAT2A (0.40) GSK3BCDK4CCND1CCND2CCND3
SCHEMBL8287197 0.83 EGFR (0.43) GSK3BCDK4CCND1CCND2CCND3
SCHEMBL5872050 0.83 GAA (0.44) GSK3BCDK4CCND1CCND2CCND3
SCHEMBL8285273 0.82 KDM4E (0.36) GSK3BCDK4CCND1CCND2CCND3
SCHEMBL8285278 0.82 MAPK1 (0.38) GSK3BCDK4CCND1CCND2CCND3
SCHEMBL8286148 0.81 GSK3B (0.36) GSK3BCDK4CCND1CCND2CCND3
SCHEMBL8287593 0.81 GSK3B (0.37) GSK3BCDK4CCND1CCND2CCND3
SCHEMBL8286162 0.80 GSK3B (0.37) GSK3BCDK4CCND1CCND2CCND3

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2005091857-A2 1,6-NAPHTHYRIDINE AND 1,8-NAPHTHYRIDINE DERIVATIVES AND THEIR USE TO TREAT DIABETES AND RELATED DISORDERS BAYER PHARMACEUTICALS CORPORATION (US) 2005-10-06 WO disclosed
WO-2003027112-A1 1, 8-NAPHTHYRIDINE DERIVATIVES AS ANTIDIABETICS BAYER PHARMACEUTICALS CORPORATION (US) 2003-04-03 WO disclosed